Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra

被引:162
作者
Brenner, M. [1 ]
Ruzicka, T. [1 ]
Plewig, G. [1 ]
Thomas, P. [1 ]
Herzer, P.
机构
[1] Univ Munich, Dept Dermatol, D-80337 Munich, Germany
关键词
anakinra; interleukin-1 receptor antagonist; pyoderma gangrenosum; PAPA (pyogenic arthritis; pyoderma gangrenosum and acne) syndrome; AUTOINFLAMMATORY DISORDER; RHEUMATOID-ARTHRITIS; INFLIXIMAB; MUTATIONS; INFLAMMASOME; IMPROVEMENT; ADALIMUMAB; DISEASES; PATHWAY; FEVER;
D O I
10.1111/j.1365-2133.2009.09404.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The triad of sterile pyogenic arthritis, pyoderma gangrenosum and acne is known by the acronym of PAPA syndrome. It is a rare autosomal dominant disease of early onset. The treatment of pyoderma gangrenosum is challenging as there is often only partial response to systemic glucocorticosteroids and immunosuppressive therapies. We report the rapid and lasting response of pyoderma gangrenosum to the targeted treatment with the recombinant human interleukin-1 receptor antagonist (rHuIL-1Ra) anakinra in a patient with PAPA syndrome.
引用
收藏
页码:1199 / 1201
页数:3
相关论文
共 27 条
[1]   NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder [J].
Agostini, L ;
Martinon, F ;
Burns, K ;
McDermott, MF ;
Hawkins, PN ;
Tschopp, J .
IMMUNITY, 2004, 20 (03) :319-325
[2]  
Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO
[3]  
2-U
[4]   Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial [J].
Brooklyn, TN ;
Dunnill, MGS ;
Shetty, A ;
Bowden, JJ ;
Williams, JDL ;
Griffiths, CEM ;
Forbes, A ;
Greenwood, R ;
Probert, CS .
GUT, 2006, 55 (04) :505-509
[5]   Anakinra for flares of pyogenic arthritis in PAPA syndrome [J].
Dierselhuis, MP ;
Frenkel, J ;
Wulffraat, NM ;
Boelens, JJ .
RHEUMATOLOGY, 2005, 44 (03) :406-408
[6]  
Fonder Margaret A, 2006, J Burns Wounds, V5, pe8
[7]   TNFRSF1A mutations and autoinflammatory syndromes [J].
Galon, J ;
Aksentijevich, I ;
McDermott, MF ;
O'Shea, JJ ;
Kastner, DL .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :479-486
[8]   Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations [J].
Gattorno, Marco ;
Tassi, Sara ;
Carta, Sonia ;
Delfino, Laura ;
Ferlito, Francesca ;
Pelagatti, Maria Antonietta ;
D'Osualdo, Andrea ;
Buoncompagni, Antonella ;
Alpigiani, Maria Giannina ;
Alessio, Maria ;
Martini, Alberto ;
Rubartelli, Anna .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :3138-3148
[9]   Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition [J].
Goldbach-Mansky, Raphaela ;
Dailey, Natalie J. ;
Canna, Scott W. ;
Gelabert, Ana ;
Jones, Janet ;
Rubin, Benjamin I. ;
Kim, H. Jeffrey ;
Brewer, Carmen ;
Zalewski, Christopher ;
Wiggs, Edythe ;
Hill, Suvimol ;
Turner, Maria L. ;
Karp, Barbara I. ;
Aksentijevich, Ivona ;
Pucino, Frank ;
Penzak, Scott R. ;
Haverkamp, Margje H. ;
Stein, Leonard ;
Adams, Barbara S. ;
Moore, Terry L. ;
Fuhlbrigge, Robert C. ;
Shaham, Bracha ;
Jarvis, James N. ;
O'Neil, Kathleen ;
Vehe, Richard K. ;
Beitz, Laurie O. ;
Gardner, Gregory ;
Hannan, William P. ;
Warren, Robert W. ;
Horn, William ;
Cole, Joe L. ;
Paul, Scott M. ;
Hawkins, Philip N. ;
Pham, Tuyet Hang ;
Snyder, Christopher ;
Wesley, Robert A. ;
Hoffmann, Steven C. ;
Holland, Steven M. ;
Butman, John A. ;
Kastner, Daniel L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) :581-592
[10]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340